Answer
Belimumab (Benlysta) should not be used during pregnancy unless the potential benefit justifies the potential risk to the foetus; pregnancy data are limited, and registry data cannot establish definitive conclusions about birth-defect risk.
Sources for this answer
- Benlysta 120 mg and 400 mg powder for concentrate for solution for infusionGlaxoSmithKline UK · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 35Document updated
Sources checked